Gearing Up for AACR: Joe Biden, The Blue Ribbon Panel and Fight CRC

The Moonshot Initiative and Joe Biden The Moonshot initiative caused quite a stir in the cancer community when announced by the Obama Administration on January 12, 2016. Why all the excitement? The Moonshot could mean a $1 billion investment to help speed up cancer research innovations…

Read Full Post

FDA Approves Avastin for New Second-Line Use

For patients with metastatic colorectal cancer, the Food and Drug Administration (FDA) has approved a new use of Avastin® (bevacizumab): It can be continued as part of ‘second-line’ combination therapy, even if it was used in first-line therapy. When stage IV cancer progresses despite use…

Read Full Post

Watch our Webinar on Drug Shortages

On Wednesday night, Dr. Lindsey Poppe, the Pharmacy Clinical Manager for Oncology for the University of North Carolina hospital system talked about the alternatives and options that patients have when directly faced with the current chemo drug shortage. You can watch a recording of the webinar…

Read Full Post